Q1 2022 Holdings
Filed 2022-05-16 | 92 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Medicus Sciences Acquisition | *W EXP 02/12/202 | G5960S124 | $25 | 57,770 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $76 | 99,999 | 0.0% |
| Social Cap Suvretta Hlds CP | CLASS A ORD SHS | G8253Y105 | $1.9K | 200,000 | 0.0% |
| Social Cap Suvretta Hlds CRP | CLASS A ORD SHS | G8253U103 | $2.0K | 200,000 | 0.0% |
| Social Cap Suvretta Hlds CRP | CLASS A ORD SHS | G8253T106 | $2.0K | 200,000 | 0.0% |
| Social Cap Suvretta HLD Crpi | CLASS A ORD SHS | G8253W109 | $2.0K | 200,000 | 0.0% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $2.1K | 544,043 | 0.0% |
| Science 37 Holdings Inc | COM | 808644108 | $2.3K | 430,000 | 0.0% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $2.3K | 560,000 | 0.0% |
| Sema4 Holdings Corp(SMFRUSD) | COM CL A | 81663L101 | $2.9K | 950,000 | 0.0% |
| Otonomy Inc | COM | 68906L105 | $3.2K | 1,349,905 | 0.0% |
| Oncosec MED Inc | COM | 68234L306 | $3.4K | 2,945,000 | 0.0% |
| Graphite BIO Inc(GRPH) | COM | 38870X104 | $3.6K | 710,000 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $4.0K | 400,000 | 0.0% |
| Field Trip Health LTD | COM | 31656R102 | $4.0K | 2,976,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $4.4K | 400,000 | 0.0% |
| Panacea Acquisition Corp II | CL A SHS | G6882C106 | $4.9K | 500,000 | 0.0% |
| Arya Sciences Acqu Corp IV | CL A | G31659108 | $4.9K | 500,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $4.9K | 500,000 | 0.0% |
| Dynamics Special Purpose COR | CLASS A COM | 268010105 | $4.9K | 500,000 | 0.0% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $5.1K | 520,000 | 0.0% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $5.3K | 1,503,754 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $5.5K | 721,000 | 0.0% |
| Caremax Inc | COM CL A | 14171W103 | $5.6K | 755,329 | 0.0% |
| Phasebio Pharmaceuticals Inc | COM | 717224109 | $5.8K | 4,405,000 | 0.0% |
| Cyteir Therapeutics Inc | COM | 23284P103 | $7.0K | 1,850,000 | 0.0% |
| Sentinelone Inc(S) | CL A | 81730H109 | $7.9K | 204,500 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $8.6K | 995,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $10.7K | 210,000 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $10.8K | 1,207,000 | 0.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $13.3K | 215,000 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $14.4K | 100,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $15.2K | 2,460,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $18.6K | 291,184 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $19.2K | 1,040,000 | 0.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $20.1K | 780,000 | 0.0% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $22.6K | 1,000,000 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $23.1K | 104,000 | 0.0% |
| Seaspine Hldgs Corp(SPNEUSD) | COM | 81255T108 | $24.4K | 2,010,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $25.4K | 3,685,000 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $25.5K | 4,855,006 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $26.5K | 1,946,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $28.3K | 390,075 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $29.5K | 1,175,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $30.1K | 2,690,000 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $31.8K | 1,354,539 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $37.8K | 2,045,000 | 0.0% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $39.5K | 440,000 | 0.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $39.8K | 1,095,000 | 0.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $40.8K | 1,363,800 | 0.0% |